Affected individuals exhibit muscle weakness, immune suppression, impairment of the GH/IGF1 axis, higher risk of diabetes, cardiovascular disease (hypertension), osteoporosis, decreased fertility, depression, and weight gain (Chabre, 2014; Ferraù and Korbonits, 2015). The gene discussed is GH1; the disease is depressive symptom measurement.